xmap-technology (Luminex)
Luminex is a verified supplier 
Luminex manufactures this product 
99
Structured Review
Luminex
xmap-technology
Xmap Technology, supplied by Luminex, used in various techniques. Bioz Stars score: 99/100, based on 14824 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/xmap-technology/xmap-technology/custom%40xmap-technology%4042615342
Average 99 stars, based on 14824 article reviews
Xmap Technology, supplied by Luminex, used in various techniques. Bioz Stars score: 99/100, based on 14824 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/xmap-technology/xmap-technology/custom%40xmap-technology%4042615342
Average 99 stars, based on 14824 article reviews
xmap-technology - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
High Throughput Screening Assay:Article Title: Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer Article Snippet: sue sections in absolute accordance with the manufacturer's operational protocol. The assay applies a multiplex PCR-based reverse sequence-specific oligonucleotide (PCR-rSSO) methodology combined with Formalin-fixed Paraffin-Embedded:Article Title: Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer Article Snippet: sue sections in absolute accordance with the manufacturer's operational protocol. The assay applies a multiplex PCR-based reverse sequence-specific oligonucleotide (PCR-rSSO) methodology combined with Amplification:Article Title: Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer Article Snippet: sue sections in absolute accordance with the manufacturer's operational protocol. The assay applies a multiplex PCR-based reverse sequence-specific oligonucleotide (PCR-rSSO) methodology combined with Multiplex Assay:Article Title: Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer Article Snippet: sue sections in absolute accordance with the manufacturer's operational protocol. The assay applies a multiplex PCR-based reverse sequence-specific oligonucleotide (PCR-rSSO) methodology combined with Luminex:Article Title: Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer Article Snippet: sue sections in absolute accordance with the manufacturer's operational protocol. The assay applies a multiplex PCR-based reverse sequence-specific oligonucleotide (PCR-rSSO) methodology combined with Hybridization:Article Title: Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer Article Snippet: sue sections in absolute accordance with the manufacturer's operational protocol. The assay applies a multiplex PCR-based reverse sequence-specific oligonucleotide (PCR-rSSO) methodology combined with Enzyme-linked Immunosorbent Assay:Article Title: Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer Article Snippet: sue sections in absolute accordance with the manufacturer's operational protocol. The assay applies a multiplex PCR-based reverse sequence-specific oligonucleotide (PCR-rSSO) methodology combined with Diagnostic Assay:Article Title: Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer Article Snippet: sue sections in absolute accordance with the manufacturer's operational protocol. The assay applies a multiplex PCR-based reverse sequence-specific oligonucleotide (PCR-rSSO) methodology combined with Prototype Assay:Article Title: Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer Article Snippet: sue sections in absolute accordance with the manufacturer's operational protocol. The assay applies a multiplex PCR-based reverse sequence-specific oligonucleotide (PCR-rSSO) methodology combined with Marker:Article Title: Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer Article Snippet: sue sections in absolute accordance with the manufacturer's operational protocol. The assay applies a multiplex PCR-based reverse sequence-specific oligonucleotide (PCR-rSSO) methodology combined with Microarray:Article Title: Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer Article Snippet: sue sections in absolute accordance with the manufacturer's operational protocol. The assay applies a multiplex PCR-based reverse sequence-specific oligonucleotide (PCR-rSSO) methodology combined with Cell Culture:Article Title: Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer Article Snippet: sue sections in absolute accordance with the manufacturer's operational protocol. The assay applies a multiplex PCR-based reverse sequence-specific oligonucleotide (PCR-rSSO) methodology combined with Software:Article Title: Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer Article Snippet: sue sections in absolute accordance with the manufacturer's operational protocol. The assay applies a multiplex PCR-based reverse sequence-specific oligonucleotide (PCR-rSSO) methodology combined with Magnetic Beads:Article Title: Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer Article Snippet: sue sections in absolute accordance with the manufacturer's operational protocol. The assay applies a multiplex PCR-based reverse sequence-specific oligonucleotide (PCR-rSSO) methodology combined with Incubation:Article Title: Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer Article Snippet: sue sections in absolute accordance with the manufacturer's operational protocol. The assay applies a multiplex PCR-based reverse sequence-specific oligonucleotide (PCR-rSSO) methodology combined with Imaging:Article Title: Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer Article Snippet: sue sections in absolute accordance with the manufacturer's operational protocol. The assay applies a multiplex PCR-based reverse sequence-specific oligonucleotide (PCR-rSSO) methodology combined with Clinical Proteomics:Article Title: Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer Article Snippet: sue sections in absolute accordance with the manufacturer's operational protocol. The assay applies a multiplex PCR-based reverse sequence-specific oligonucleotide (PCR-rSSO) methodology combined with Staining:Article Title: Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer Article Snippet: sue sections in absolute accordance with the manufacturer's operational protocol. The assay applies a multiplex PCR-based reverse sequence-specific oligonucleotide (PCR-rSSO) methodology combined with |